|
26
|
|
$6.92M
|
+$7.24M
|
+620,523
|
+1,639%
|
|
|
27
|
Janus Henderson Group
London,
|
$6.71M
|
-$775K
|
-66,437
|
-9%
|
|
|
28
|
|
$5.39M
|
+$4.19M
|
+359,604
|
+235%
|
|
|
29
|
Stempoint Capital
New York
|
$5.17M
|
-$6.16M
|
-528,288
|
-52%
|
|
|
30
|
Adage Capital Partners
Boston,
Massachusetts
|
$5.06M
|
-$1.64M
|
-140,248
|
-23%
|
|
|
31
|
Alyeska Investment Group
Chicago,
Illinois
|
$4.94M
|
–
|
–
|
–
|
|
|
32
|
|
$4.17M
|
+$2.18M
|
+187,000
|
+89%
|
|
|
33
|
Samsara BioCapital
Palo Alto,
California
|
$4.16M
|
–
|
–
|
–
|
|
|
34
|
MPM BioImpact
Boston,
Massachusetts
|
$4.15M
|
+$4.61M
|
+395,237
|
New
|
|
|
35
|
Affinity Asset Advisors
New York
|
$3.68M
|
+$1.75M
|
+150,000
|
+75%
|
|
|
36
|
TD Asset Management
Toronto,
Ontario, Canada
|
$3.36M
|
+$1.08M
|
+92,638
|
+41%
|
|
|
37
|
Platinum Investment Management
Sydney Australia 2000,
Australia
|
$3.03M
|
-$290K
|
-24,885
|
-8%
|
|
|
38
|
|
$2.85M
|
-$235K
|
-20,121
|
-7%
|
|
|
39
|
Hudson Bay Capital Management
Stamford,
Connecticut
|
$2.36M
|
-$2.92M
|
-250,557
|
-53%
|
|
|
40
|
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$2.36M
|
+$2.59M
|
+222,460
|
+9,087%
|
|
|
41
|
Two Sigma Investments
New York
|
$2.31M
|
-$1.33M
|
-113,893
|
-34%
|
|
|
42
|
Gratus Capital
Atlanta,
Georgia
|
$2.05M
|
+$2.28M
|
+195,276
|
New
|
|
|
43
|
Two Sigma Advisers
New York
|
$1.66M
|
+$230K
|
+19,700
|
+14%
|
|
|
44
|
DAFNA Capital Management
Los Angeles,
California
|
$1.52M
|
+$466K
|
+40,000
|
+38%
|
|
|
45
|
Schroder Investment Management Group
London,
United Kingdom
|
$1.45M
|
+$1.61M
|
+137,739
|
New
|
|
|
46
|
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
$1.39M
|
+$749K
|
+64,196
|
+94%
|
|
|
47
|
Crestline Management
Fort Worth,
Texas
|
$1.28M
|
+$1.42M
|
+122,036
|
New
|
|
|
48
|
Geode Capital Management
Boston,
Massachusetts
|
$925K
|
+$42.7K
|
+3,659
|
+4%
|
|
|
49
|
|
$658K
|
+$730K
|
+62,632
|
New
|
|
|
50
|
Ikarian Capital
Dallas,
Texas
|
$519K
|
+$4.48K
|
+384
|
+0.8%
|
|
